MedPath
FDA Approval

Granisetron Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 31, 2017
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Granisetron(1 mg in 1 mL)

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Granisetron Hydrochloride

Product Details

NDC Product Code
67457-864
Application Number
ANDA091137
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2017
Code: 318F6L70J8Class: ACTIMQuantity: 1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Granisetron Hydrochloride

Product Details

NDC Product Code
67457-863
Application Number
ANDA091136
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2017
Code: 318F6L70J8Class: ACTIMQuantity: 1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Granisetron Hydrochloride

Product Details

NDC Product Code
67457-861
Application Number
ANDA091136
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2017
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
Code: 318F6L70J8Class: ACTIMQuantity: 0.1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath